The FDA approved the Supplemental New Drug Application for phentolamine 0.75% (Ryzumvi, Opus Genetics/Viatris) to treat presbyopia.
Alice Epitropoulos, MD
Advertisement
Articles by Alice Epitropoulos, MD
Preparing the ocular surface for surgery in the presence of Demodex blepharitis
Published: | Updated:
Alice Epitropoulos, MD, shares cases of Demodex blepharitis and reflects on how lotilaner has changed treatment before ocular surgery.
Advertisement
Latest Updated Articles
Preparing the ocular surface for surgery in the presence of Demodex blepharitisPublished: August 21st 2026 | Updated: September 3rd 2026
- Preparing the ocular surface for surgery in the presence of Demodex blepharitis
Published: August 21st 2026 | Updated: September 3rd 2026
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Practical ways to extend anti-VEGF control in RVO, AMD, and DME
2
FDA approves ranibizumab biosimilar Lucamzi for wet AMD
3
Mediterranean diet linked to slower AMD progression across stages
4
AAO 2026 recap: Christopher J. Rapuano, MD, on the meeting's themes
5